The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991

scientific article published on 01 March 2000

The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991 is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1053/RMED.1999.0733
P698PubMed publication ID10783936

P2093author name stringLöfdahl CG
Jacobson L
Lindgren B
Skoogh BE
Hertzman P
P433issue3
P921main subjectSwedenQ34
asthmaQ35869
chronic obstructive pulmonary diseaseQ199804
P304page(s)247-255
P577publication date2000-03-01
P1433published inRespiratory MedicineQ2659932
P1476titleThe economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991
P478volume94

Reverse relations

cites work (P2860)
Q34309884An economic overview of chronic obstructive pulmonary disease
Q35939354Annual costs of chronic obstructive pulmonary disease in Finland during 1996-2006 and a prediction model for 2007-2030.
Q44272728Asthma and allergy: the significance of chronic conditions for individual health behaviour
Q35863966Burden and clinical features of chronic obstructive pulmonary disease (COPD).
Q36042283COPD patients' rights: Can they be won?
Q28387753Cancer risk in hospitalised asthma patients
Q57777724Clinical Outcomes and Cost Analysis of Exacerbations in Chronic Obstructive Pulmonary Disease
Q44638346Cost-utility analysis of a pharmacy-led self-management programme for patients with COPD.
Q34341891Design and analytic considerations in determining the cost-effectiveness of early intervention in asthma from a multinational clinical trial.
Q43596144Direct costs to primary care of chronic bronchitis. Analysis of a prospective study
Q36980698Disproportionate utilization of healthcare resources among veterans with COPD: a retrospective analysis of factors associated with COPD healthcare cost
Q44442777Drug treatment of chronic obstructive pulmonary disease on two levels of patient care: degree of compliance with recommended protocols
Q73152295Economic analysis of the Confronting COPD survey: methodology
Q42661119Economic assessment of adjustable maintenance treatment with budesonide/formoterol in a single inhaler versus fixed treatment in asthma
Q34381765Impact of dropout of female volunteer community health workers: an exploration in Dhaka urban slums
Q34167388Inhaled salmeterol/fluticasone propionate combination. A pharmacoeconomic review of its use in the management of asthma
Q57128698Living with asthma in Sweden--the ALMA study
Q36859405Optimizing economic outcomes in the management of COPD.
Q35906562Present and future costs of COPD in Iceland and Norway: results from the BOLD study
Q38663315Socioeconomic impact of asthma, chronic obstructive pulmonary disease and asthma-COPD overlap syndrome
Q34801118The burden of chronic obstructive pulmonary disease
Q35205449The costs of hospitalization in patients with acute exacerbation of chronic obstructive pulmonary disease.
Q51681417The economic impact of COPD in North America and Europe. Analysis of the Confronting COPD survey. Introduction.
Q50736607[Costs of chronic obstructive pulmonary disease in Spain. Estimation from a population-based study]

Search more.